IP Library Granted Patent US 9,034,414
Granted Patent B2
US 9,034,414 · App. 14/186,183 · Granted May 19, 2015

Biomaterial, joint prosthesis using the biomaterial and method of producing the same

Inventors: Masayuki Kyomoto (Osaka, JP); Kazuhiko Ishihara (Tokyo, JP); Yasuhiko Iwasaki (Tokyo, JP); Toru Moro (Tokyo, JP); Kozo Nakamura (Tokyo, JP); Yoshio Takatori (Tokyo, JP); Hiroshi Kawaguchi (Tokyo, JP); Tomohiro Konno (Tokyo, JP); Noboru Yamawaki (Osaka, JP)
Assignees: KYOCERA MEDICAL CORPORATION; THE UNIVERSITY OF TOKYO; NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
A61L27/34Y10T428/24917Y10T428/24926A61F2/30767A61F2/32A61F2/34A61F2002/30685A61F2002/30934A61F2002/3611A61F2310/00011A61F2310/00179A61L27/42B23K35/3618C22F1/11C22F1/183B05D1/18B05D3/067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,034,414
App. No.
14/186,183
Granted
May 19, 2015
Kind
B2
Abstract

The object of the present invention is to provide a joint prosthesis, bearing material and a production method thereof, which suppresses wear in a sliding section and suppresses the production of abrasive powder even during repeated daily operation. To achieve the object, there is provided a biomaterial comprising: a substrate made of metal, alloy or ceramic; and a biocompatible material layer laminated on the substrate, wherein hydroxyl groups are formed on the substrate by surface-treating, while the biocompatible material layer comprises a polymer containing phosphorylcholine groups, the substrate and the biocompatible material layer are bound via a binder layer which is combined with the hydroxyl groups of the substrate and with the biocompatible material layer.

Claims (13)

1. A method for producing a biomaterial having a substrate made of a metal, an alloy or a ceramic material and a biocompatible material layer laminated at appropriate positions on the substrate, comprising the steps of:

(a) plasma-treating the substrate made of a metal, an alloy or a ceramic material containing a metal component or a metal oxide capable of forming hydroxyl groups to form hydroxyl groups on the surface of the substrate;

(b) applying a solution containing a binder constituent to the substrate and then drying the solution to form a binder layer thereon, the binder constituent being an organic compound having carboxyl groups on one terminal and methacrylic groups or methylene groups on the other terminal; and

(c) immersing the substrate in a solution containing a biocompatible material and a photo-initiator and then polymerizing the biocompatible material monomer on the binder layer by UV irradiation to graft-coat the biocompatible material layer on the binder layer.

2. The method for producing a biomaterial according to claim 1 , wherein the substrate is made of at least one selected from the group consisting of cobalt-chromium alloy, cobalt-chromium-molybdenum alloy, nickel-chromium alloy, and stainless steel alloy, and the step (a) further comprises a pre-treatment in which a surface of the alloy substrate is treated with nitric acid to increase a concentration of chromium on the surface of the substrate.

3. The method for producing a biomaterial according to claim 2 , wherein the binder is made of at least one selected from the group consisting of 4-methacryloxyethyltrimellitate anhydride and 4-methacryloyloxy ethyl trimellitic acid, while the biocompatible material is made of a polymer containing phosphorylcholine groups,

and the biocompatible material layer is laminated on the substrate by the binder.

4. The method for producing a biomaterial according to claim 2 , wherein the binder layer is made of at least one selected from the group consisting of 4-methacryloxyethyltrimellitate anhydride, 4-methacryloyloxy ethyl trimellitic acid and methacrylic acid, while the biocompatible material layer is made of 2-methacryloyloxyethyl phosphorylcholine,

the methacrylic groups in 4-methacryloxyethyltrimellitate anhydride, 4-methacryloyloxy ethyl trimellitic acid or methacrylic acid react with the methacrylic groups in 2-methacryloyloxyethyl phosphorylcholine into the formation of covalent bonds,

and the biocompatible material layer is laminated on the substrate by carboxyl groups in the binder layer.

5. The method for producing a biomaterial according to claim 2 , wherein the binder layer is made of at least one selected from the group consisting of maleic anhydride and maleic acid, while the biocompatible material layer is made of 2-methacryloyloxyethyl phosphorylcholine,

methacrylic groups in the 2-methacryloyloxyethyl phosphorylcholine monomer are combined with radicals as nucleus for the graft-polymerization, the radicals being produced by cleaving C—H bond in the maleic anhydride or maleic acid,

the biocompatible material layer is laminated on the substrate by carboxyl groups in the binder layer.

Assignments (1)
MERGER Recorded Dec 29, 2017
From: KYOCERA MEDICAL CORPORATION
To: KYOCERA CORPORATION
Reel/Frame 044504/0082 →
Priority Claims (1)
JP 2006-091544 · Mar 29, 2006 · national
Continuity (2)
Division 12225758
Related Publication 20140170331A1 · Jun 19, 2014